Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Rachel M. Belcher, Crosby Oldham, A. Marie Rapier & Daniel Gutteridge. (2021) Hydroxocobalamin and extracorporeal membrane oxygenation (ECMO) for severe refractory shock in bupropion and citalopram overdose: a case report. Toxicology Communications 5:1, pages 136-139.
Read now
Read now
James B. Leonard & Wendy Klein-Schwartz. (2019) Characterization of intentional-abuse venlafaxine exposures reported to poison control centers in the United States. The American Journal of Drug and Alcohol Abuse 45:4, pages 421-426.
Read now
Read now
Christopher E. Gaw, Henry A. Spiller, Jason L. Russell, Thiphalak Chounthirath & Gary A. Smith. (2018) Evaluation of dose and outcomes for pediatric vilazodone ingestions. Clinical Toxicology 56:2, pages 113-119.
Read now
Read now
Jason L. Russell, Henry A. Spiller, Thiphalak Chounthirath & Marcel J. Casavant. (2017) Pediatric ingestion of vilazodone compared to other selective serotonin reuptake inhibitor medications. Clinical Toxicology 55:5, pages 352-356.
Read now
Read now
Mohammad Sayyah, Sayeh Majzoob & Mehdi Sayyah. (2013) Metabolic and toxicological considerations for obsessive–compulsive disorder drug therapy. Expert Opinion on Drug Metabolism & Toxicology 9:6, pages 657-673.
Read now
Read now
Michael A. Darracq, Alycia Clark, Lily Qian & F. Lee Cantrell. (2013) A retrospective review of isolated duloxetine-exposure cases. Clinical Toxicology 51:2, pages 106-110.
Read now
Read now
Wendy Klein-Schwartz, Blaine E. Benson, Samantha C. Lee & Toby Litovitz. (2012) Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children. Clinical Toxicology 50:5, pages 418-423.
Read now
Read now
MathiasB. Forrester & Gilbert Parra. (2008) Compliance with Selective Serotonin Reuptake Inhibitor Triage Guidelines by Texas Poison Control Centers. Journal of Toxicology and Environmental Health, Part A 71:5, pages 304-309.
Read now
Read now
Articles from other publishers (58)
I. Claudet. (2023) Intoxicaciones domésticas accidentales en la infancia. EMC - Pediatría 58:3, pages 1-22.
Crossref
Crossref
Abderrahim Titi, Rachid Touzani, Anna Moliterni, Taibi Ben Hadda, Mouslim Messali, Redouanae Benabbes, Malika Berredjem, Abdeslem Bouzina, Nabil Al-Zaqri, Mustapha Taleb, Abdelkader Zarrouk & Ismail Warad. (2022) Synthesis, structural, biocomputational modeling and antifungal activity of novel armed pyrazoles. Journal of Molecular Structure 1264, pages 133156.
Crossref
Crossref
Lara Prisco, Aarti Sarwal, Mario Ganau & Francesca Rubulotta. (2021) Toxicology of Psychoactive Substances. Critical Care Clinics 37:3, pages 517-541.
Crossref
Crossref
Melanie Hüttenrauch, José Sócrates Lopez-Noguerola & Susana Castro-Obregón. (2021) Connecting Mind-Body Therapy-Mediated Effects to Pathological Features of Alzheimer’s Disease. Journal of Alzheimer's Disease 82:s1, pages S65-S90.
Crossref
Crossref
Diana Apetauerova, Pritika A. Patel, Joseph D. Burns & David P. Lerner. (2021) Movement Disorder Emergencies. Neurologic Clinics 39:2, pages 615-630.
Crossref
Crossref
Fabrizio Schifano, Stefania Chiappini, Andrea Miuli, John Martin Corkery, Norbert Scherbaum, Flavia Napoletano, Davide Arillotta, Caroline Zangani, Valeria Catalani, Alessandro Vento, Mauro Pettorruso, Giovanni Martinotti, Di Giannantonio Massimo & Amira Guirguis. (2021) New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review. Experimental Neurology 339, pages 113638.
Crossref
Crossref
Claudia Vignali, Matteo Moretti, Jessica Quaiotti, Francesca Freni, Luca Tajana, Antonio Marco Maria Osculati & Luca Morini. (2021) Distribution of Fluvoxamine and Identification of the Main Metabolite in a Fatal Intoxication. Journal of Analytical Toxicology 45:4, pages e1-e5.
Crossref
Crossref
David P. Lerner, Aleksey Tadevosyan & Joseph D. Burns. (2020) Toxin-Induced Subacute Encephalopathy. Neurologic Clinics 38:4, pages 799-824.
Crossref
Crossref
Amberly R. Johnson, Casey R. Tak, Kathleen Anderson, Bradley Dahl, Cathie Smith & Barbara I. Crouch. (2020) Poison-related visits in a pediatric emergency department: A retrospective analysis of patients who bypass poison control centers. The American Journal of Emergency Medicine 38:8, pages 1554-1559.
Crossref
Crossref
James Clevenger & Daniel McCabe. (2020) Development of severe serotonin syndrome from acute ingestion of vilazodone without co-ingestion. The American Journal of Emergency Medicine 38:5, pages 1045.e1-1045.e2.
Crossref
Crossref
Jared MendelsohnBarbara J. Coffey. (2019) Serotonin Syndrome in an Adolescent Girl. Journal of Child and Adolescent Psychopharmacology 29:10, pages 783-786.
Crossref
Crossref
Benjamin Laliberte & Omayma A. Kishk. (2018) Serotonin Syndrome in a Pediatric Patient After Vilazodone Ingestion. Pediatric Emergency Care 34:12, pages e226-e228.
Crossref
Crossref
Alfredo F. Gei, Victor R. Suarez & James W. Van Hook. 2018. Critical Care Obstetrics. Critical Care Obstetrics
927
983
.
Pedro Correia, Joana Afonso Ribeiro, Conceição Bento & Francisco Sales. (2018) Negative myoclonus secondary to paroxetine intake. BMJ Case Reports, pages bcr-2018-224586.
Crossref
Crossref
Ekramy Elmorsy, Ayat Al-Ghafari, Fahd M. Almutairi, Amal Misbah Aggour & Wayne G. Carter. (2017) Antidepressants are cytotoxic to rat primary blood brain barrier endothelial cells at high therapeutic concentrations. Toxicology in Vitro 44, pages 154-163.
Crossref
Crossref
Tom MunyerJames Leonard & Bruce Anderson. 2017. PharmacotherapyFirst: A Multimedia Learning Resource. PharmacotherapyFirst: A Multimedia Learning Resource.
Dana Bartlett. (2017) Drug-Induced Serotonin Syndrome. Critical Care Nurse 37:1, pages 49-54.
Crossref
Crossref
I. Claudet. (2016) Intoxications domestiques accidentelles de l’enfant. Journal de Pédiatrie et de Puériculture 29:5, pages 244-268.
Crossref
Crossref
Toby Litovitz, Blaine E. Benson & Susan Smolinske. (2016) webPOISONCONTROL: can poison control be automated?. The American Journal of Emergency Medicine 34:8, pages 1614-1619.
Crossref
Crossref
Jinyoung Kim, Minseob Kim, Yoo-ra Kim, Kyoung Ho Choi & Kyoung-Uk Lee. (2015) High Prevalence of Psychotropics Overdose among Suicide Attempters in Korea. Clinical Psychopharmacology and Neuroscience 13:3, pages 302-307.
Crossref
Crossref
I. Claudet. (2015) Intoxicaciones domésticas accidentales en la infancia. EMC - Pediatría 50:4, pages 1-19.
Crossref
Crossref
Sébastien Beaune, Emmanuel Curis, Enrique Casalino, Philippe Juvin & Bruno Mégarbane. (2015) Do Serotonin Reuptake Inhibitors Worsen Outcome of Patients Referred to the Emergency Department for Deliberate Multi-drug Exposure?. Basic & Clinical Pharmacology & Toxicology 116:4, pages 372-377.
Crossref
Crossref
Rui Tao, Ibrahim M. Shokry, John J. Callanan, H. Daniel Adams & Zhiyuan Ma. (2014) Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats. Psychopharmacology 232:7, pages 1245-1260.
Crossref
Crossref
James McKean, Hannah Watts & Robert Mokszycki. (2015) Breakthrough Seizures after Starting Vilazodone for Depression. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35:3, pages e6-e8.
Crossref
Crossref
Joseph Villarreal, Christopher A. Kahn, James V. Dunford, Ekta Patel & Richard F. Clark. (2015) A retrospective review of the prehospital use of activated charcoal. The American Journal of Emergency Medicine 33:1, pages 56-59.
Crossref
Crossref
Tomomichi Kan'o, Yoshihito Kamijo, Jun Hattori, Fumie Kashimi, Chie Sato & Kuniko Yoshimura. (2015) Refractory status epilepticus, circulatory collapse after cardiac arrest, and acute respiratory distress syndrome caused by severe isolated fluvoxamine poisoning: a case report. Acute Medicine & Surgery 2:1, pages 53-55.
Crossref
Crossref
Rui Tao, Mary Rudacille, Gongliang Zhang & Zhiyuan Ma. (2014) Changes in Intensity of Serotonin Syndrome Caused by Adverse Interaction between Monoamine Oxidase Inhibitors and Serotonin Reuptake Blockers. Neuropsychopharmacology 39:8, pages 1996-2007.
Crossref
Crossref
Janice E. Sullivan & Mark J. McDonald. 2014. Pediatric Critical Care Medicine. Pediatric Critical Care Medicine
695
727
.
Nasim Zamani & Omid Mehrpour. (2013) Outpatient treatment of the poisoned patients in Iran; may it be a feasible plan?. DARU Journal of Pharmaceutical Sciences 21:1.
Crossref
Crossref
J. Dave Barry & Brandon K. Wills. (2013) Neurotoxic Emergencies. Psychiatric Clinics of North America 36:2, pages 219-244.
Crossref
Crossref
M. Maignan & V. Danel. (2013) Prise en charge préhospitalière des intoxications aiguës gravesSevere poisoning management in the prehospital setting. Annales françaises de médecine d'urgence 3:2, pages 95-102.
Crossref
Crossref
Kevin T. Fitzgerald & Alvin C. Bronstein. (2013) Selective Serotonin Reuptake Inhibitor Exposure. Topics in Companion Animal Medicine 28:1, pages 13-17.
Crossref
Crossref
Brad E. CooperCeleste A. Sejnowski. (2013) Serotonin Syndrome: Recognition and Treatment. AACN Advanced Critical Care 24:1, pages 15-20.
Crossref
Crossref
Odile Spreux-Varoquaux. (2013) Le syndrome ou toxidrome sérotoninergique : étiologies, signes cliniques centraux et périphériques. L'information psychiatrique 89:10, pages 819.
Crossref
Crossref
Brad E. Cooper & Celeste A. Sejnowski. (2013) Serotonin Syndrome. AACN Advanced Critical Care 24:1, pages 15-20.
Crossref
Crossref
Ross J. BaldessariniRoss J. Baldessarini. 2013. Chemotherapy in Psychiatry. Chemotherapy in Psychiatry
155
250
.
Danielle E. Thomas, Justine A. Lee & Lynn R. Hovda. (2012) Retrospective evaluation of toxicosis from selective serotonin reuptake inhibitor antidepressants: 313 dogs (2005-2010). Journal of Veterinary Emergency and Critical Care 22:6, pages 674-681.
Crossref
Crossref
Ross Hodges. (2012) Serotonin toxicity: pre-hospital recognition and management. Journal of Paramedic Practice 4:9, pages 509-515.
Crossref
Crossref
Lisa Wilson, Thomas Rooney, Reginald F. Baugh & Belinda Millington. (2012) Recognition and management of perioperative serotonin syndrome. American Journal of Otolaryngology 33:3, pages 319-321.
Crossref
Crossref
Ping-Tao Tseng, Yu Lee, Ya-En Lin & Pao-Yen Lin. (2012) Low-dose escitalopram for 2 days associated with corrected QT interval prolongation in a middle-aged woman: a case report and literature review. General Hospital Psychiatry 34:2, pages 210.e13-210.e15.
Crossref
Crossref
Rania Slika. 2012. Textbook of Clinical Pediatrics. Textbook of Clinical Pediatrics
2601
2604
.
J. Dave Barry & Brandon K. Wills. (2011) Neurotoxic Emergencies. Neurologic Clinics 29:3, pages 539-563.
Crossref
Crossref
B. Juan Pablo Acuña. (2011) Intoxicación grave por psicofármacos. Revista Médica Clínica Las Condes 22:3, pages 332-339.
Crossref
Crossref
John W. Kreit. 2011. Textbook of Critical Care. Textbook of Critical Care
1303
1307
.
Marla Sanzone. 2011. Encyclopedia of Clinical Neuropsychology. Encyclopedia of Clinical Neuropsychology
2270
2275
.
Mathias B. Forrester. (2010) Compliance with Atypical Antipsychotic Triage Guidelines by Texas Poison Centers. Journal of Medical Toxicology 6:4, pages 403-407.
Crossref
Crossref
Alfredo F. Gei & Victor R. Suarez. 2010. Critical Care Obstetrics. Critical Care Obstetrics
514
558
.
S. Bin Salih, M. Al Qahtani, T. Al Anazi, M. Al Hussein, H. Al Hayyan & H. Al Modaimegh. (2010) Metabolic acidosis and generalized seizures secondary to citalopram overdose: a case report. Journal of Clinical Pharmacy and Therapeutics.
Crossref
Crossref
John Kelly. 2010. Principles of CNS Drug Development. Principles of CNS Drug Development
173
210
.
Mathias B Forrester. (2009) Comparison of Immediate-Release and Controlled-Release Paroxetine Ingestions Reported to Texas Poison Control Centers between 2002 and 2008. Journal of Pharmacy Technology 25:3, pages 169-175.
Crossref
Crossref
Klaus Romero & Raymond L. Woosley. (2009) Clarification to the www.qtdrugs.org updated lists. Pharmacoepidemiology and Drug Safety 18:5, pages 423-424.
Crossref
Crossref
Li-Jen Lee. (2009) Neonatal Fluoxetine Exposure Affects the Neuronal Structure in the Somatosensory Cortex and Somatosensory-Related Behaviors in Adolescent Rats. Neurotoxicity Research 15:3, pages 212-223.
Crossref
Crossref
Melody Ryan & Kara A. Kennedy. 2009. Clinical Neurotoxicology. Clinical Neurotoxicology
348
357
.
M Forrester. (2008) Reply to comments on escitalopram and lisinopril ingestion articles. Human & Experimental Toxicology 27:10, pages 739-739.
Crossref
Crossref
Tomer T. Levin, Alberto Cortes-Ladino, Mark Weiss & M. Lia Palomba. (2008) Life-threatening serotonin toxicity due to a citalopram-fluconazole drug interaction: case reports and discussion. General Hospital Psychiatry 30:4, pages 372-377.
Crossref
Crossref
Zhiyuan Ma, Gongliang Zhang, Chris Jenney, Swapna Krishnamoorthy & Rui Tao. (2008) Characterization of serotonin-toxicity syndrome (toxidrome) elicited by 5-hydroxy-l-tryptophan in clorgyline-pretreated rats. European Journal of Pharmacology 588:2-3, pages 198-206.
Crossref
Crossref
Asim F. Tarabar, Robert S. Hoffman & Lewis S. Nelson. (2008) Citalopram overdose: Late presentation of torsades de pointes (TdP) with cardiac arrest. Journal of Medical Toxicology 4:2, pages 101-105.
Crossref
Crossref
Allan V. Kalueff, Justin L. LaPorte & Dennis L. Murphy. (2008) Perspectives on genetic animal models of serotonin toxicity. Neurochemistry International 52:4-5, pages 649-658.
Crossref
Crossref